Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Dorinsky, C. LaForce, K. Rickard, N. Herje, E. Brooks (Morrisville, Raleigh, Littleton, United States Of America). Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists. Eur Respir J 2013; 42: Suppl. 57, 3557

Member's Comments

No comment yet.

Related content which might interest you: Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Exhaled nitric oxide and the therapeutic regimens in childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide in asthma: Relationship with breath gymnastic and FeNO levels Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Meta analysis of asthma exacerbation rates in adult and pediatric asthmatics managed using fractional exhaled nitric oxide versus standard clinical parameters alone Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Exhaled nitric oxide (FeNO) levels to guide treatment for adults with asthma: A Cochrane systematic review Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Interaction between airway calibre and exhaled NO: Impact on asthma control assessment Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled nitric oxide (FeNO) levels to guide treatment for children with asthma: A Cochrane systematic review Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Further evidence that FeNO directed therapy reduces asthma exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Associations between fractional exhaled nitric oxide (FeNO), asthma, respiratory symptoms and self-reported allergies in female university students in Kobe, Japan Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Effect of spirometry and bronchodilation test in eNO levels Source: International Congress 2016 – The future of lung function is beginning now Year: 2016